LanguaTalk

Surfing the MASH Tsunami

Driving the Discussion in Fatty Liver Disease. Join hepatology researcher and Key Opinion Leader Jörn Schattenberg, Liver Wellness Advocate Louise Campbell, and Forecasting and Pricing Guru Roger Green and a global group of Key Opinion Leaders and patient advocates as they discuss key issues in Fatty Liver disease, including epidemiology, drug development, clinical pathways, non-invasive testing, health economics and regulatory issues, from their own unique perspectives on the Surfing the MASH Tsunami podcast. #MASH #MAFLD #FattyLiver #livertwitter #AASLD #GlobalLiver #NoNASH #EASL

S6.14.3 - Louise and Roger React to Empowered SLD Patient Advocates

20 mins; October 07, 2025

S6.14.2 - Goals of the Stephen A. Harrison Patient Advocacy Fellowship Program

19 mins; October 07, 2025

S6.14.1 - How the Harrison Patient Advocacy Fellowship Came To Be

38 mins; October 07, 2025

S6.14 - Introducing the Dr. Stephen A. Harrison Patient Advocacy Fellowship Program

67 hours 34 mins; October 03, 2025

S6.13.3 - Major Issues in MASH-ville: US Government Chaos and Scanning Market Dynamism

37 mins; September 11, 2025

S6.13.2 -

20 mins; September 09, 2025

S6.13.1 - Major Issues: Developing a More Integrated Approach to MASH Patient Management

19 mins; September 09, 2025

6,13 - Locating MASH patients, Population Screening for Advanced Disease, Impact of Washington on Americans' Health

73 hours 53 mins; September 04, 2025

S6.12.3 - After the Semaglutide Approval: What Next For MASH Therapy?

21 mins; September 02, 2025

S6.12.2 - After the Semaglutide Approval: Expanding MASH Awareness Will Change Medical Practices

22 mins; August 31, 2025

S6.12.1 - After the Semaglutide Approval: Impact on Patients and Pharmacotherapy

24 mins; August 31, 2025

S6.12 - A Second US Drug Approval! What Semaglutide's Success Portends For MASLD Care in the US

64 hours 23 mins; August 28, 2025

6.11.3 - Expert: Emily Andaya Asks Why There Is No "L" In the (Multi-Meatbolic) CKM Initiative

41 mins; August 17, 2025

6.11.2 - Multi-Metabolic Week Part II: Benefits of the Multi-Metabolic Approach

43 mins; August 17, 2025

6.11.1 - Multi-Metabolic Week Part I: Role of MASLD In Multi-Metabolic Clinics

37 mins; August 16, 2025

Multi-metabolic practices integrate MASLD with other non-communicable diseases

109 hours 45 mins; August 14, 2025

6.10.3 - Expert: Tim Jobson on Using Basic Data and Analytics to Identify At-Risk Patients

37 mins; August 10, 2025

6.10.2 - Newsmakers: LiverRight Launches America's First Virtual Hepatology Clinic

30 mins; August 09, 2025

6.10.1 - FIrst Six Months, Part I: The Promise of Proteomics For Developing Individualized Treatment Plans

27 mins; August 09, 2025

6.10 - New Approaches to Patient Care: NIT-driven drug choices, Virtual Clinics, Large-Scale Screening

92 hours 25 mins; August 07, 2025

6.9.3 - Expert: Naim Alkhouri Discusses His Long Friendship with Stephen Harrison and His New Role at Summit Clinical Research

29 mins; August 06, 2025

6.9.2 - Newsmaker: Fatty Liver Alliance President Mike Betel Discusses His 3rd Annual 30-Day Glucose Challenge

39 mins; August 05, 2025

6.9.1 - #SLDThinkTank2025, Part III: Unique Challenge of Nutrition Management and Role Politicians Can Play

23 mins; August 05, 2025

6.9 - Complexities of Behavior Change, Devices That Can Help, Future of Clinical Trials and MedEd

77 hours 21 mins; August 01, 2025

S6 E8.3 - Deep Dive into Drug Development IV: Other Modes Of Action; Metabolic vs. Pleiotropic Effects

16 mins; July 29, 2025

6.8.2 - newsmaker: GLI President and CEO Larry Holden discusses Changes in Washington and How We Can Proceed

31 mins; July 28, 2025

6.8.1 - #SLDThinkTank2025 Part II: Complexities and Challenges of Behavior Change

16 mins; July 28, 2025

S6 E8 - Hybrid Interventions; Washington Challenges; Two-Target Treatment

62 hours 58 mins; July 25, 2025

S6 - E7.3 - Deep Dive into Drug Development, Part III: NITs in Drug Development

14 mins; July 24, 2025

S6 - E7.2 - Patient Advocate Jose Willemse on Patient-Centered Care

33 mins; July 22, 2025

S6 - E7.1 - #SLDThinkTank2025 Part I: Hybrid Interventions Integrate AI and Human Care

22 mins; July 22, 2025

S6 - E7 - Barcelona SLD Conference Highlight; NITs in Drug Development

69 hours 20 mins; July 17, 2025

S6 - E6 - Remembering Stephen Harrison and His Many Contributions to MASH

57 mins; April 26, 2025

S6 - E5.3 - Expert: Scott Friedman on Gene Therapy and Advances in Liver Science

23 mins; April 24, 2025

S6 - E5.2 - Newsmaker: Naga Chalasani on Real-World Experience Prescribing Resmetirom

26 mins; April 24, 2025

S6 - E5.1 - FGF-21s and A Promising Future on Cirrhosis

24 mins; April 22, 2025

S6 - E5 - Drug Development Week: FGF-21s, Cirrhosis, Resmiterom, Gene Therapies

69 hours 0 mins; April 18, 2025

S6 - E4.3 - Expert: Mazen Noureddin Reviews the Exciting MASLD Drug Development Environment

24 mins; April 13, 2025

S6 - E4.2 - Newsmaker: Fatty Liver Alliance Founder Mike Betel Discusses the Increased Visibility of Patient Advocates

31 mins; April 12, 2025

S6 - E4.1 - MASLD Drugs, SLD Spectrum Insights Suggest Bright Future

20 mins; April 12, 2025

S6 - E4 - Reasons for optimism in MASLD drug development and patient advocacy

72 hours 42 mins; April 11, 2025

S6 - E3.3 - Expert: GLI's Jeff McIntyre discusses implications of FDA job cuts on MASH drugs

31 mins; April 06, 2025

S6 E3.2 - Newsmakers: FibroSIGHT™ Brings Clinical Trial Analytics to the Clinic

28 mins; April 05, 2025

S6- E3.1 - Roundtable: Spotting Tomorrow’s Trends in Today's MASLD Studies

15 mins; April 05, 2025

S6 - E3 - Drugs and Diagnostics Evolve as the FDA Devolves

72 hours 31 mins; April 03, 2025

S6 - E2 - MetALD Epidemiology, MASLD Mortality and a PCP "Unicorn"

71 hours 36 mins; March 27, 2025

S6 - E1: Two Multispecialty February Conferences and Europe Prepares for Resmetirom

73 hours 24 mins; March 21, 2025

S5 - E26.5 - Looking Back at #TLM2024 - Promoting Healthy Livers and Looking Ahead to 2025

15 mins; January 03, 2025

S5 - E26.4 - Looking Back at #TLM2024 - Patient Advocacy and Patient-Centric Trials

11 mins; January 03, 2025

S5 - E26.2 - Looking Back at #TLM2024 - Patient Genotyping and MASH Clusters

14 mins; January 02, 2025

S5 - E26.3 - Looking Back at #TLM2024 - FGF-21 Agents and the FDA Corner

13 mins; January 02, 2025

S5 - E26.1 - Looking Back at #TLM2024 - Semaglutide Passes the ESSENCE Test

13 mins; January 02, 2025

S5-26 - One Month Later: Looking Back at MASLD/MASH Coverage From The Liver Meeting 2024

71 hours 25 mins; December 20, 2024

S5 - E25 - Reviewing Expert Recommendations on the Use of Resmetirom

42 mins; August 09, 2024

S4 - E24.5 - SurfingMASH Question of The Week: Keys to Improving Provider-Patient Communication

20 mins; August 08, 2024

S5 - E24.4 - EASL Congress Six Weeks Later: Jeff McIntyre's Key Implications for GLI

18 mins; August 07, 2024

S5 - E24.3 - EASL Congress Six Weeks Later: Jeff McIntyre's Key Takeaways

12 mins; August 07, 2024

S5 - E24.2 - EASL Congress Six Weeks Later: Mathieu Petitjean's Key Implications

10 mins; August 07, 2024

S5 - E24.1 - EASL Congress Six Weeks Later: Mathieu Petitjean's Key Takeaways

17 mins; August 07, 2024

S5 - E24 - A view of MASLD: Looking back at EASL Congress from six weeks later

76 hours 26 mins; August 03, 2024

S5 SPECIAL 5 - Reviewing EASL Congress: Louise Campbell 3 (first-time material)

9 mins; July 21, 2024

S5 SPECIAL 4 - Reviewing EASL Congress: Sven Francque

17 mins; July 20, 2024

S5 SPECIAL 3 - Reviewing EASL Congress: Louise Campbell 2

20 mins; July 20, 2024

S5 SPECIAL 2 - Reviewing EASL Congress: Louise Campbell I

20 mins; July 19, 2024

S5 SPECIAL 1 - Reviewing EASL Congress: Mike Betel

13 mins; July 19, 2024

S5 - E23.6 - From The Vault: Improving Patient Self-Management And Key Takeaways On Nutrition For MASH Resolution

29 mins; July 16, 2024

S5 - E23.5 - From the EASL Congress: The Need for Shared Experience MASLD Support Groups and Programs

11 mins; July 16, 2024

S5 - E23.4 - From the EASL Congress: Socioeconomic And Psychological Issues In The Physician-Patient Dialogue

12 mins; July 16, 2024

S5 - E23.3 - From The EASL Congress: Improving The Physician-Patient Dialogue

12 mins; July 15, 2024

S5 - E23.2 - From The EASL Congress: Dynamics Of The Physician-Patient Dialogue

11 mins; July 15, 2024

S5 - E23.1 - From The EASL Congress: Overview Of Challenges In Physician-Patient Communication

14 mins; July 15, 2024

S5 - E23 - Lessons from EASL Congress: Challenges in Provider-Patient Communication

58 mins; July 12, 2024

S5 - E22.6 - FROM THE VAULT: Patient Advocates Reflect On How The "System" Views MASH

12 mins; July 08, 2024

S5 - E22.5 - Healthy Livers, Healthy Lives: Watershed Moments To Come In MASLD Publlc Policy

10 mins; July 08, 2024

S5 - E22.4 - Healthy Livers, Healthy Lives: The Role Of The Updated EASL MASLD Guidelines And Big Data

10 mins; July 07, 2024

S5 - E22.3 - Healthy Livers, Healthy Lives: Challenges and Promise in Building a Global MASLD Health Policy

10 mins; July 07, 2024

S5 - E22.2 - Healthy Livers, Healthy Lives: "Political Will" In MASLD Public Policy

12 mins; July 07, 2024

S5 - E22.1 - Healthy Livers, Healthy Lives: Why MASHville Needs This Coalition

13 mins; July 07, 2024

S5 - E22 - Healthy Livers, Healthy Lives: A Global SLD Public Health Coalition

45 mins; July 04, 2024

S5 - E21.6 - From The Vault: Comments On The 2023 AASLD Revised Practice Guidance

11 mins; June 30, 2024

S5 - E21.5 - The Updated MASLD CPG: Implications For Healthcare Systems

12 mins; June 30, 2024

S5 - E21.4 - The Updated MASLD CPG: Pharmacology And New Educational Needs

11 mins; June 30, 2024

S5 - E21.3 - The Updated MASLD CPG: Screening, Diagnosing And Managing Patients

13 mins; June 29, 2024

S5 - E21.2 - The Updated MASLD CPG: Benefits Of The Collaboration

11 mins; June 29, 2024

S5 - E21.1 - The Updated MASLD CPG: Introductions

9 mins; June 29, 2024

S5 - E21 - Reviewing The Updated ESL-EASD-EASO MASLD Clinical Practice Guidelines

52 mins; June 27, 2024

S5 - E20.6 - From the Vault: FGF-21s and "Twin-cretins" At EASL Congress 2023

14 mins; June 23, 2024

S5 - E20.5 - Drug Development Highlights From EASL Congress 2024: Denifenstat, SPECIAL and Other Stories

13 mins; June 23, 2024

S5 - E20.4 - Drug Development Highlights From EASL Congress 2024: Are FGF-21s Induction Therapy or a "MASH Cure"?

10 mins; June 23, 2024

S5 - E20.3 - Drug Development Highlights From EASL Congress 2024: "Twin-cretins" and efruxifermin

14 mins; June 22, 2024

S5 - E20.2 - Drug Development Highlights From EASL Congress 2024: Tirzepatidate and other "Twin-cretins"

11 mins; June 22, 2024

S5 - E20.1 - Drug Development Highlights From EASL Congress 2024: Resmetirom

10 mins; June 22, 2024

S5 - E20 - Lessons From EASL Congress 2024: Exciting Advances in Drug Development

57 mins; June 20, 2024

EASL Congress 2024: Interviews From A Seminal Meeting For MASLD & MASH

70 hours 16 mins; June 13, 2024

S5 - E18.5 - How Listeners Can Support HOPE, A Unique Support Community For People Who Have Harmed Their Bodies Through Alcohol Use Disorder

9 mins; June 11, 2024

S5 - E18.4 - The Future Of HOPE: Expanding the Support Community for Patients Who Have Harmed Their Bodies Through Alcohol Use Disorder

10 mins; June 11, 2024

S5 - E18.3 - Specific Support Elements HOPE Provides For People Who Have Harmed Themselves Due To Alcohol Use Disorder

11 mins; June 11, 2024

S5 - E18.2 - Why People Who Have Harmed Themselves Through Alcohol Use Disorder Need HOPE

9 mins; June 11, 2024

S5 - E18.1 - Introducing HOPE, A Project For People Who Have Harmed Their Bodies Through Alcohol Use DIsorder

12 mins; June 11, 2024

S5 - E18 - Introducing HOPE, a support program for patients living with the effects of ALD and cirrhosis

48 mins; June 06, 2024

Click here to see more

Surfing the MASH Tsunami

Useful pages

Find a tutor

Languages